| Date | Programmes | Podcast Title | |
|---|---|---|---|
| 17-Feb-25 |
Market Watch (7:00 AM) |
It Makes Sense To Diversify
Michael Lai, Executive Director , OCBC Bank |
|
| 14-Feb-25 |
Market Watch (7:00 AM) |
Tariffs Might Be Priced in Already
Yeap Jun Rong, Market Strategist , IG International |
|
| 13-Feb-25 |
Market Watch (7:00 AM) |
Inflation Points To Higher For Longer Rates
Tony Nash, CEO, Complete Intelligence |
|
| 12-Feb-25 |
Market Watch (7:00 AM) |
Emerging Market Currencies In A Flux
Carlos Casanova, Senior Economist, UBP |
|
| 07-Feb-25 |
Market Watch (7:00 AM) |
Diversify To Asia, It Makes Sense
Tim Mulholland, President, TJM Limited |
|
| 06-Feb-25 |
Market Watch (7:00 AM) |
Fed Has No Choice But To Wait And See
Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank |
|
| 28-Jan-25 |
Market Watch (7:00 AM) |
Deepseek's Impact On US Markets
Joe Quinlan, Chief Market Strategist, US Trust-BOA Private Wealth Management |
|
| 27-Jan-25 |
Market Watch (7:00 AM) |
Tariffs Might Change Fed Trajectory
Kingsley Jones, Chief Investment Officer, Jevons Global |
|
| 24-Jan-25 |
Market Watch (7:00 AM) |
US Markets Priced to Perfection, So Caveat Emptor
Tim Mulholland, President, TJM Limited |
|
| 23-Jan-25 |
Market Watch (7:00 AM) |
The Trump 2.0 Impact So Far
Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank |
|
| 22-Jan-25 |
Market Watch (7:00 AM) |
Market Reaction To Trump 2.0
Song Seng Wun, Economic Advisor, CGS International Securities |
|
| 21-Jan-25 |
Market Watch (7:00 AM) |
US Markets And Dollar To Reign Supreme Again
Joe Quinlan, Chief Market Strategist, US Trust-BOA Private Wealth Management |
|
| 20-Jan-25 |
Market Watch (7:00 AM) |
Limited Policy Levers In Trump 2.0
Laurent Lequeu, Independent Market Analyst & Writer, The Macro Butler Newsletter |
|
| 17-Jan-25 |
Market Watch (7:00 AM) |
Whither US Equities In 2025 With A New US Administration?
Yeap Jun Rong, Market Strategist, IG International |
|
| 16-Jan-25 |
Market Watch (7:00 AM) |
Trading Strategies Ahead Of A Trump 2.0
Tony Nash, CEO, Complete Intelligence |
|
| 15-Jan-25 |
Market Watch (7:00 AM) |
US Inflation Trajectory And The Feds' 2025 Strategy
Carlos Casanova, Senior Economist, UBP |
|
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Ringgit & Sense
Jennifer Chua, licensed Financial Advisor at UOB Kay Hian talks about the ins and outs of planning for your parents' aged care.
Open For Business
How Nexacore Aims to Solve the ‘Last Mile’ Problem in Device Insurance
Tech Talk
Enterprise Explores
The Breakfast Grille Repeat
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we delve into the next stage of Malaysia's development, examining economic policy, structural challenges, and pathways for equitable growth.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
Talkback Thursday
BBC World Service
